RMD - ResMed Inc.
| Previous Close | 99.22 |
| Open | 98.78 |
| Bid | 99.33 x 1000 |
| Ask | 99.42 x 800 |
| Day's Range | 98.76 - 101.14 |
| 52 Week Range | 90.64 - 118.50 |
| Volume | 151,418 |
| Avg. Volume | 1,153,441 |
| Market Cap | 14.262B |
| Beta (3Y Monthly) | 0.55 |
| PE Ratio (TTM) | 31.91 |
| EPS (TTM) | 3.12 |
| Earnings Date | May 2, 2019 |
| Forward Dividend & Yield | 1.48 (1.42%) |
| Ex-Dividend Date | 2019-02-06 |
| 1y Target Est | 107.57 |
- Zacks•10 days ago
ResMed Launches AirFit P30i Nasal Pillows Mask in the US
ResMed (RMD) to expand its portfolio of sleep apnea devices on the back of AirFit P30i nasal pillows mask.
- Business Wire•11 days ago
ResMed to Report Third Quarter Fiscal 2019 Earnings on May 2, 2019
ResMed today announced it plans to release financial and operational results for the third quarter of fiscal year 2019 on Thursday, May 2, 2019, after the New York Stock Exchange closes.
- Zacks•11 days ago
ResMed's Brightree Widens ReSupply Solution Usage for HME
Resmed's (RMD) Brightree ReSupply is a scalable and automated solution that comprises live-agent inbound and outbound calls for more private interaction with patients and email reminder capabilities.
- Business Wire•11 days ago
ResMed Introduces AirFit P30i, Its First Top-of-Head-Connected Nasal Pillows CPAP Mask
Now offers “tube-up” design options for nasal and nasal pillows mask wearers, providing even more flexibility and choice to help users sleep better in any position
- Business Wire•12 days ago
Brightree ReSupply Solution Expands Beyond Sleep to 3 More Disease Segments
- Solution expands to incontinence, diabetic, and enteral segments
- Zacks•17 days ago
ResMed's (RMD) Brightree Unveils Analytics Platform for HME
The Analytics arm, launched by ResMed (RMD) unit Brightree, provides workflow insights and facilitates KPI tracking plus peer benchmarking without the users having to amass the data themselves.
- Zacks•18 days ago
ResMed (RMD) Rides on International Growth & Innovation
We expect ResMed's (RMD) new product menu and strategies to gain traction from the sleep-disordered breathing market and further drive its near-term performance.
- Business Wire•18 days ago
Brightree Introduces First-of-its-kind Analytics Suite for HMEs
HMEs can now see workflow insights, KPI tracking, and peer benchmarking on one auto-produced dashboard to enhance business decision-making
- Simply Wall St.•20 days ago
Something To Consider Before Buying ResMed Inc. (NYSE:RMD) For The 1.4% Dividend
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Dividends can be underrated but they form a large part of investment returns, playing an important role in compounding return...
- Zacks•20 days ago
Walgreens Boots (WBA) Q2 Earnings Lag Estimates, Margins Down
A difficult macroeconomic environment and market challenges made the fiscal second quarter the toughest since the formation of Walgreens Boots Alliance (WBA).
- Zacks•20 days ago
Here's Why You Should Invest in Illumina (ILMN) Stock Now
Illumina (ILMN) is currently keeping well with its goals to strengthen foothold in the multi-billion gene sequencing market.
- Insider Monkey•22 days ago
Were Hedge Funds Right About Souring On ResMed Inc. (RMD)?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They generate significant returns for investors to justify their large fees and they allocate a lot of time and employ a complex analysis to determine the best stocks to invest in. A particularly […]
- Zacks•25 days ago
ResMed (RMD) Introduces ReSupply Solution, Expands in HME
ResMed (RMD) claims ReSupply solution to improve patient response through growth in the long-term therapy adherence of those suffering sleep apnea.
- GlobeNewswire•26 days ago
Investor Expectations to Drive Momentum within United Technologies, Third Point Reinsurance, Consolidated Communications, Covanta Holding, Modine Manufacturing, and ResMed — Discovering Underlying Factors of Influence
NEW YORK, March 27, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- Business Wire•28 days ago
ResMed Launches Next-generation ReSupply Solution
Brand-agnostic solution helps HMEs provide timely PAP replacement supplies to sleep apnea patients, increases long-term adherence and improves satisfaction
- Business Wire•last month
ResMed to Host an Investor Meeting on April 4, 2019
ResMed (RMD) (RMD.AX) today announced it will host an investor meeting on Thursday, April 4th to discuss the Company’s recent acquisitions, existing joint ventures and strategy pertaining to respiratory care and out-of-hospital software. Additional information regarding the investor meeting, including the specific time and webcast link for the presentations, will be made available approximately one week prior to the event and may be accessed by visiting http://investor.resmed.com. Presentations at the investor meeting will be transmitted by a live webcast, which may be accessed by visiting http://investor.resmed.com.
- Simply Wall St.•last month
Do You Like ResMed Inc. (NYSE:RMD) At This P/E Ratio?
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll show how you can use ResMed Inc.'s (NYSE:RMD) P/E ratio toRead More...
- Markit•last month
See what the IHS Markit Score report has to say about ResMed Inc.
ResMed Inc NYSE:RMDView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for RMD with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold RMD had net inflows of $5.37 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•last month
ResMed's New Brightree Suite to Boost Home Infusion Business
ResMed's (RMD) Brightree suite upgrade will help uplift business operations by easily meeting compliance needs and offering the best quality patient care.
- Zacks•last month
Resmed (RMD) to Acquire HB Healthcare to Treat Sleep Apnea
ResMed (RMD) to expand in CPAP and respiratory care market in Korea.
- Business Wire•2 months ago
ResMed Acquires HB Healthcare to Help Millions of Koreans Living with Sleep Apnea, Other Respiratory Conditions
ResMed (NYSE: RMD, ASX: RMD), a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, today announced that is has completed the acquisition of HB Healthcare (HBH) to help millions of South Koreans living with sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions. HBH, a fast-growing privately owned South Korean home medical equipment provider, serves both reimbursed and cash-pay customers of sleep and respiratory care devices.
- Business Wire•2 months ago
Brightree Announces Enhanced Pharmacy Suite
- Home infusion therapy providers and HME pharmacies benefit from feature-rich functionality within a single software solution for all clinical, billing and reporting needs
- Zacks•2 months ago
ResMed Inks Deal With PharMerica on Medication Management
The deal between ResMed's (RMD) MatrixCare and PharMerica covers NCPDP (National Council for Prescription Drug Programs) Bidirectional ePrescribing with all MatrixCare customer facilities.
- GlobeNewswire•2 months ago
Factors of Influence in 2019, Key Indicators and Opportunity within Franklin Resources, Heartland Express, Ameriprise Financial, Merck & Co., NGL Energy Partners LP, and ResMed — New Research Emphasizes Economic Growth
NEW YORK, Feb. 28, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- GlobeNewswire•2 months ago
MatrixCare Signs National Agreement with PharMerica for NCPDP Bidirectional and Pharmacy-Centric Order Integration
BLOOMINGTON, Minn., Feb. 27, 2019 -- MatrixCare announced today that it has entered into a National Pharmacy Integration and Electronic Medication Administration Record (eMAR).
